Cargando…

Modification of tumour blood flow using the hypertensive agent, angiotensin II.

The effects of different doses of angiotensin II (0.02 to 0.5 microgram kg-1 min-1 on mean arterial blood pressure, tissue blood flow and tissue vascular resistance were investigated in BD9 rats. Blood flow was measured using the uptake of 125I- or 14C-labelled iodoantipyrine (125I-IAP and 14C-IAP)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Tozer, G. M., Shaffi, K. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968475/ https://www.ncbi.nlm.nih.gov/pubmed/8494732

Ejemplares similares

The response of tumour vasculature to angiotensin II revealed by its systemic and local administration to 'tissue-isolated' tumours.
por: Tozer, G. M., et al.
Publicado: (1995)

Characterisation of tumour blood flow using a 'tissue-isolated' preparation.
por: Tozer, G. M., et al.
Publicado: (1994)

Reduced capacity of tumour blood vessels to produce endothelium-derived relaxing factor: significance for blood flow modification.
por: Tozer, G. M., et al.
Publicado: (1996)

Resistance to flow through tissue-isolated transplanted rat tumours located in two different sites.
por: Sensky, P. L., et al.
Publicado: (1993)

The endothelin B (ET(B)) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification
por: Cemazar, M, et al.
Publicado: (2005)

Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastases
por: Burke, D, et al.
Publicado: (2001)

Fluctuations in Tumor Blood Flow under Normotension and the Effect of Angiotensin II‐induced Hypertension
por: Hori, Katsuyoshi, et al.
Publicado: (1991)

The effects of hyperoxic and hypercarbic gases on tumour blood flow
por: Dunn, T J, et al.
Publicado: (1999)

CD4(+) Regulatory T Lymphocytes Prevent Impaired Cerebral Blood Flow in Angiotensin II‐Induced Hypertension
por: Iulita, M. Florencia, et al.
Publicado: (2018)

Blood flow modification by nicotinamide and metoclopramide in mouse tumours growing in different sites.
por: Hirst, D. G., et al.
Publicado: (1993)

Monitoring blood flow to colorectal liver metastases using laser Doppler flowmetry: the effect of angiotensin II.
por: Hemingway, D. M., et al.
Publicado: (1992)

The role of IL-6 in the physiologic versus hypertensive blood pressure actions of angiotensin II
por: Manhiani, M Marlina, et al.
Publicado: (2015)

Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension.
por: Tozer, G. M., et al.
Publicado: (1990)

Estradiol Supplement or Induced Hypertension May Attenuate the Angiotensin II Type 1 Receptor Antagonist-Promoted Renal Blood Flow Response to Graded Angiotensin II Administration in Ovariectomized Rats
por: Choopani, Samira, et al.
Publicado: (2022)

RENAL HYPERTENSION IN RATS IMMUNIZED AGAINST ANGIOTENSIN I AND ANGIOTENSIN II
por: Oates, Helen F., et al.
Publicado: (1974)

In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification.
por: Bremner, J. C., et al.
Publicado: (1991)

Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
por: Kang, Si-Hyuck, et al.
Publicado: (2021)

Renal Inhibition of Heme Oxygenase-1 Increases Blood Pressure in Angiotensin II-Dependent Hypertension
por: Csongradi, Eva, et al.
Publicado: (2012)

The relationship between regional variations in blood flow and histology in a transplanted rat fibrosarcoma.
por: Tozer, G. M., et al.
Publicado: (1990)

Effect of angiotensin II blockade on central blood pressure and arterial stiffness in subjects with hypertension
por: Safar, Michel E
Publicado: (2010)

Role of blood cell-associated angiotensin II type 1 receptors in the cerebral microvascular response to ischemic stroke during angiotensin-induced hypertension
por: Nagai, Mutsumi, et al.
Publicado: (2011)

The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour.
por: Goldberg, J. A., et al.
Publicado: (1991)

Disparate responses of tumour vessels to angiotensin II: tumour volume-dependent effects on perfusion and oxygenation
por: Thews, O, et al.
Publicado: (2000)

Dual deficiency of angiotensin‐converting enzyme‐2 and Mas receptor enhances angiotensin II‐induced hypertension and hypertensive nephropathy
por: Ni, Jun, et al.
Publicado: (2020)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang, Chao, et al.
Publicado: (2021)

The Effect of Intra-Arterial Angiotensin II on the Hepatic Tumor to Non-Tumor Blood Flow Ratio for Radioembolization: A Systematic Review
por: van den Hoven, Andor F., et al.
Publicado: (2014)

Angiotensin II and the Cardiac Parasympathetic Nervous System in Hypertension
por: Shanks, Julia, et al.
Publicado: (2021)

Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure
por: Vacková, Šárka, et al.
Publicado: (2019)

Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice
por: Ching, L-M, et al.
Publicado: (2004)

Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosensitised tumour necrosis.
por: Milanesi, C., et al.
Publicado: (1990)

The Effects of Angiotensin II and Angiotensin-(1–7) in the Rostral Ventrolateral Medulla of Rats on Stress-Induced Hypertension
por: Du, Dongshu, et al.
Publicado: (2013)

Effects of Angiotensin-(1-7) and Angiotensin II on Acetylcholine-Induced Vascular Relaxation in Spontaneously Hypertensive Rats
por: Zhang, Feng, et al.
Publicado: (2019)

The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension
por: Li, Mingfei, et al.
Publicado: (2021)

Angiotensin II accelerates mammary gland development independently of high blood pressure in pregnancy-associated hypertensive mice
por: Murata, Kazuya, et al.
Publicado: (2015)

Angiotensin II and AT(1a) Receptors in the Proximal Tubules of the Kidney: New Roles in Blood Pressure Control and Hypertension
por: Leite, Ana Paula de Oliveira, et al.
Publicado: (2022)

The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients: Is there a room for vitamin D?
por: Sukkarieh, Hatouf H., et al.
Publicado: (2020)

The effect of blood flow modification on intra- and extracellular pH measured by 31P magnetic resonance spectroscopy in murine tumours.
por: McCoy, C. L., et al.
Publicado: (1995)

Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor
por: Cha, Seung Ah, et al.
Publicado: (2018)

Deletion of the angiotensin II type 1 receptor–associated protein enhances renal sodium reabsorption and exacerbates angiotensin II–mediated hypertension
por: Ohsawa, Masato, et al.
Publicado: (2014)

The role of plasma angiotensin II and angiotensin-converting enzyme 2 levels on prognosis and mortality in hypertensive patients with COVID-19
por: Biberoğlu, Serap, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3qqfqu6nssmo7qkoq097v210jq